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Abstract
The infant gut microbiota develops rapidly during the first 2 years of life, acquiring microorganisms from diverse sources.
During this time, significant opportunities exist for the infant to acquire antibiotic resistant bacteria, which can become
established and constitute the infant gut resistome. With increased antibiotic resistance limiting our ability to treat bacterial
infections, investigations into resistance reservoirs are highly pertinent. This study aimed to explore the nascent resistome in
antibiotically-naı¨ve infant gut microbiomes, using a combination of metagenomic approaches. Faecal samples from 22 six-
month-old infants without previous antibiotic exposure were used to construct a pooled metagenomic library, which was
functionally screened for ampicillin and gentamicin resistance. Our library of ,220Mb contained 0.45 ampicillin resistant
hits/Mb and 0.059 gentamicin resistant hits/Mb. PCR-based analysis of fosmid clones and uncloned metagenomic DNA,
revealed a diverse and abundant aminoglycoside and b-lactam resistance reservoir within the infant gut, with resistance
determinants exhibiting homology to those found in common gut inhabitants, including Escherichia coli, Enterococcus sp.,
and Clostridium difficile, as well as to genes from cryptic environmental bacteria. Notably, the genes identified differed from
those revealed when a sequence-driven PCR-based screen of metagenomic DNA was employed. Carriage of these antibiotic
resistance determinants conferred substantial, but varied (2–512x), increases in antibiotic resistance to their bacterial host.
These data provide insights into the infant gut resistome, revealing the presence of a varied aminoglycoside and b-lactam
resistance reservoir even in the absence of selective pressure, confirming the infant resistome establishes early in life,
perhaps even at birth.
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Introduction
There is growing concern that we are rapidly approaching a
post-antibiotic era. As a result every effort is being made to
discover and investigate antibiotic resistance reservoirs with the
aim of limiting the selection for, or dissemination of, antibiotic
resistance genes. One such reservoir is the human gut microbiota.
Colonized by trillions of bacteria representing hundreds of
different species, this ecosystem has been identified as a source
of antibiotic resistant bacteria [1–3]. Though vastly less complex
and considerably less stable than the adult gut microbiota, the gut
microbiota of infants also has the potential to acquire and
disseminate antibiotic resistant genes [4]. From the commence-
ment of labour, the sterile infant gut rapidly becomes colonized [5]
and from birth through to 2 years of age the infant gut microbiota
is dynamic, unstable and becomes increasingly complex, until it
resembles that of an adult. The identity of the first colonizers of the
infant gut depends on numerous factors [6,7] including mode of
delivery [8], and pre-term versus full-term gestation [9] and,
because of the aforementioned instability of this microbial
population, many factors including feeding choice [10], probiotic
or prebiotic supplementation [11] and antibiotic exposure [12] can
significantly impact on its subsequent development. Indeed, in a
previous study, we have demonstrated that the infant microbiota
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becomes dominated by Proteobacteria following ampicillin and
gentamicin administration in the first 48 hours of life [13], which
may be due to the known high prevalence of antibiotic resistant
species within this phylum [14]. Such findings suggest that the
infant gut microbiota, though immature and in constant flux, can
be a source of resistant bacteria which can become dominant
following antibiotic exposure. Given the instability of the infant
microbiota in early life, there is considerable opportunity for the
infant gut to acquire resistant populations which, if they become
established, could have significant effects on shaping the compo-
sition of the microbiota later in life [15].
While it is known that antibiotic resistance genes are present
within the gut microbiota from early life [4,16], data with respect
to the presence of antibiotic resistance genes in healthy infants
with no history of antibiotic treatment is still limited [4].
Furthermore, much of the existing data comes from studies
investigating resistance genes in specific commensals, such as
strains of Escherichia coli or Lactobacillus [17,18], rather than the
entire microbiota. Challenges in studying gut microbiota are well
documented [6] and include an inability to culture the majority of
gut microbes in a laboratory environment [19]. However,
metagenomic libraries provide the opportunity to capture
metagenomic DNA from complex environments and to function-
ally screen for phenotypes of interest. The limited existing data
available from adult [1,20] and infant [21,22] metagenomic banks
indicate that human gut microbiota is a source of diverse antibiotic
resistance genes. To date, however, there is a significant paucity in
infant functional metagenomic studies, particularly relating to
infants free from antibiotic treatment. Thus, the aim of this study
was to construct a fosmid bank using metagenomic DNA from 6-
month-old infants who had never received antibiotic treatment
and to screen for the presence of antibiotic resistance genes. By 6
months of age, the infants will have acquired an increasingly
complex microbiota and will have had the opportunity to acquire
antibiotic resistant strains from numerous sources [5,23]. Our goal
was to provide insight into the infant gut microbiota as a reservoir
for resistance genes, when no antibiotic selective pressure exists,
using a combination of functional metagenomics and PCR-based
approaches. Due to the on-going focus of our research [13], we
specifically investigated resistance to aminoglycosides and b-
lactam antibiotics. Using both a function-based and function-
independent approach, we successfully identified a variety of
aminoglycoside and b-lactam resistance genes in the gut micro-
biota of infants, providing insights into the infant gut resistome.
Materials and Methods
Recruitment of volunteers
Infants were recruited as part of the INFANTMET study
(http://eldermet.ucc.ie). Parents of infant participants provided
written informed consent. Approval for the INFANTMET study
was received from the Clinical Research Ethics Committee of the
Cork Teaching Hospitals, Cork, Ireland. Infants participating in
the study had no antibiotics administered for the first 6 months of
life. Fresh faecal samples were collected from 22 6-month-old
infants and immediately stored at 280uC until processed.
DNA extraction
Due to the small volume of each individual sample, it was
necessary to pool faecal samples prior to DNA extraction. Faecal
samples were homogenized and a 500 mg aliquot from each were
pooled to form one sample from which high molecular weight
metagenomic DNA was extracted, using a previously described
method [24–26]. Briefly, faecal samples were homogenized in PBS
(Sigma Aldrich, Dublin, Ireland), centrifuged at 1000g65mins and
the supernatant retained. Nycodenz (Axis Shield, UK) density
gradient separation was performed to separate out the bacterial
cells. Enzymatic digestion of the cells using lysozyme and
mutanolysin (Sigma Aldrich) was performed, and subsequently
the protein was removed using Proteinase K and ammonium
acetate treatment (Sigma Aldrich). DNA was then purified and
precipitated using standard chloroform and ethanol precipitation
procedures and was eluted in TE buffer.
Metagenomic bank creation
To allow functional screening of the metagenomic DNA from
the infant gut, a fosmid metagenomic bank was created using the
EpiCentre CopyControl Fosmid Library Production kit with the
pCC1FOS vector, according to the manufacturer’s instructions
(Cambio, Cambridge, England). Briefly, size selection was
performed on the metagenomic DNA using pulse field gel
electrophoresis (PFGE) (0.56 TAE; 0.1initial/10 final switch
times; 4V; 17 hours; 14uC) and fragments of ,40 Kb were gel
extracted from the low melting point agarose (Promega, Medical
Supply Company, Dublin). Fragments were then ligated with the
pCC1FOS vector according to the manufacturer’s instructions
and subsequently packaged into EPI300-T1R E. coli plating strain
cells. These cells were then plated onto LB agar plates (Difco,
Becton, Dickinson & Co, Oxford, England) containing 12.5 mg/ml
chloramphenicol, IPTG and Xgal (Sigma Aldrich) and grown
overnight aerobically at 37uC. To verify the diversity of the library,
random white clones were selected and were digested with PstI
and NdeI restriction enzymes (New England Biolabs, UK), to
determine if different DNA insert sequences were present in our
metagenomic bank. The entire library was plated and then picked
and stocked in 384-well-format using the QPix2-XT robotic
system (Molecular Devices, Berkshire, UK) and was stored at
280uC until screening. A library of,220Mb of DNA was created.
Screening for antibiotic resistant clones
Due to the ongoing focus of our research [13,27], we chose to
concentrate on the resistance of infant gut microbiota to 2 groups
of antibiotics, namely the aminoglycosides and b-lactams. For
screening of the metagenomic bank, the library was plated onto
LB agar with 12.5 mg/ml chloramphenicol and inhibitory
concentrations of ampicillin (50 mg/ml) or gentamicin
(10 mg/ml) (Sigma Aldrich). These levels of antibiotics were
chosen due to their inhibition of host EPI 300-T1R E. coli cells.
The library was plated in triplicate and plates were incubated
aerobically at 37uC for 24–36 hours. Clones found to be resistant
over three replicate plates were selected, their resistance pheno-
type verified by re-streaking onto agar containing the relevant
antibiotic and were stocked for further analysis.
PCR analysis
To investigate which resistance genes were present in the insert
DNA that conferred resistance, PCRs were carried out on each of
these clones using primers for aminoglycoside and b-lactam
resistance genes (Table 1). For the aminoglycosides, we used
degenerate primers designed to amplify the acetylation (AAC; aac
(3)-I, aac (3)-II, aac (3)-III, aac (3)-VI and aac (6)), adenylation
(ANT; ant (20)-Ia) and phosphorylation (APH; aph (20)-Ic and aph
(20)-Id) genes [28], as well as the bifunctional gene aac (69)-Ie-
aph(20)-Ia [29,30]. For b-lactam resistance the primer sets for the
Antibiotic Resistance in the Infant Gut Microbiota
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following genes were used blaTEM [31,32], blaOXA [33], blaSHV
[33], blaROB [32] and blaCTX-M [34] (Table 1). Resistant clones
were grown overnight in LB broth supplemented with chloram-
phenicol (12.5 mg/ml) and either ampicillin (50 mg/ml) or
gentamicin (10 mg/ml). Fosmids were extracted from the clones
using the QIAprep Spin Mini Prep kit (Qiagen, Sussex, UK) and
subsequently used as template DNA for PCR analysis. PCRs were
performed using previously outlined protocols [28-34]. Each
reaction contained 25 ml of Biomix Red (MyBio, UK), 1 ml
forward primer (10pmol), 1 ml reverse primer (10pmol), fosmid
DNA (at the volume required to correspond to 64 ng) from the
resistant clone, and PCR grade water (Bioline, Medical Supply
Company, Dublin, Ireland) to a final reaction volume of 50 ml. All
reactions were performed in duplicate. PCR products were
visualized using gel electrophoresis (1.5% agarose, 16 TAE,
100V). Negative controls, in which the DNA template was
substituted with PCR-grade water, failed to generate an amplicon,
ruling out the possibility of contamination. Successful duplicate
PCRs were pooled and cleaned using AMPure (Beckman Coulter
UK) magnetic bead-based purification procedures.
To determine if additional resistance genes were present in the
infant gut microbiome that had not been captured in the
metagenomic bank, additional PCRs for detecting resistance
genes were performed on the metagenomic DNA which was used
for construction of the fosmid bank. PCR analysis was performed
using the primers and protocols outlined above. Following PCR
amplification, amplicons were cloned using the TOPO TA cloning
kit (Invitrogen, Dublin, Ireland) according to the manufacturer’s
instructions. TOPO cloning reactions were then transformed into
E. coli TOP 10 cells and plated on LB agar containing antibiotics
for the selection of the cloning vector (either kanamycin 50 mg/ml
or ampicillin 50 mg/ml). Plasmids were then extracted from
overnight cultures of the TOPO sub-clones using the QIAprep
Spin Mini Prep kit (Qiagen, Sussex, UK) to facilitate subsequent
DNA sequencing.
Sequencing and analysis
A subset of PCR products from the resistant fosmid clones were
sent for Sanger sequencing to determine their closest homologue
(Source Biosciences, Dublin, Ireland). The subset included
representatives from each of the genes investigated and from
clones containing multiple resistance genes. Plasmid DNA from a
subset of the TOPO sub-clones of the metagenomic DNA PCR
products were also sent for Sanger sequencing. Sequencing reads
were BLASTed against the NCBI non-redundant database using
BLASTx (http://blast.ncbi.nlm.nih.gov/). In the event where
multiple hits occurred, the BLAST hit which displayed greatest
homology (based on E value) is reported.
Minimum inhibitory concentration assays
Minimum inhibitory concentration (MIC) tests were conducted
on gentamicin (GentR) and ampicillin resistant (AmpR) fosmid
clones to determine the level of resistance conferred by the insert
DNA. In order to determine the relative increase in resistance,
MICs were compared to the control strain (EPI300-T1R E. coli +
empty pCC1FOS fosmid). MICs were performed according to the
British Society for Antimicrobial Chemotherapy guidelines [35].
An antibiotic range of 256–0.25 mg/L was used. Positive (broth +
inoculum only) and negative controls (broth + antibiotic only) were
included in each assay. Plates were incubated aerobically at 37uC
for 24 hours. The MIC was determined as the lowest concentra-
tion of antibiotic at which no visible growth occurred.
Results
Identification of gentamicin and ampicillin resistant
clones within the infant gut microbiome using a
functional metagenomic bank
Ten white clones were picked at random from LB agar plates
containing 12.5 mg/ml chloramphenicol, IPTG and X-gal and
underwent restriction digestion using PstI and NdeI restriction
enzymes. These randomly selected clones had unique restriction
profiles (data not shown), establishing that the metagenomic
library contained different insert DNA, demonstrating a diverse
metagenomic fosmid bank had been successfully created. Our
library contained ,220Mb of metagenomic DNA, which
contained 0.45 ampicillin resistant hits/Mb and 0.059 gentamicin
resistant hits/Mb. To determine which genes were responsible for
the resistance in the isolated clones, PCR analysis was conducted
on each of the resistant clones using primers for b-lactam and
aminoglycoside resistance genes (sequencing files available at
http://dx.doi.org/10.6070/H46971H6). Furthermore, to deter-
mine if additional genes could be detected in the uncloned
metagenomic DNA, PCR analysis was completed on this DNA
with the same degenerate primers as used on the resistant clones
(Figure 1).
PCR and Sanger sequencing of b-lactam resistant clones
Analysis of the one hundred AmpR clones using blaTEM primers,
revealed that they all contained blaTEM genes (Table 2). Based on
sequencing analysis, these genes shared closest homology with
blaTEM genes from uncultured soil bacteria (clones 2, 3, 4, 5, 6, 10,
16, 17, 123, 128), Shigella sp. (clone 4), Serratia marcescens (clone
126) and Citrobacter freudii (clones 17 and 18) (Table 2).
Sequencing of amplicons generated using the same blaTEM
primers and uncloned metagenomic DNA, revealed a number of
different blaTEM genes that shared closest homology with genes
from Klebsiella pneumoniae, E. coli, Salmonella enterica and
Staphylococcus aureus (Table 3).
PCRs revealed that half of the AmpR clones contained blaCTX-M
genes (including CTX-M-1 and CTX-M-36 gene homologues),
which shared homology with 1 of 3 different blaCTX-M genes present
in E. coli. Sequencing of blaCTX-M PCR products generated directly
from metagenomic DNA identified additional sources of these
genes, detecting genes that shared homology with blaCTX-M genes
present in E. coli (including one source that was not detected in the
analysis of the AmpR clones) and K. pneumoniae (Table 3).
Just 2 of the 100 AmpR clones gave PCR products using the
blaOXA primers, which surprisingly resembled 2 different blaTEM
genes, rather than blaOXA genes, from a variety of E. coli. No
blaOXA genes were amplified when PCR was directly applied to
the metagenomic DNA from the infant faecal samples. Six of the
100 AmpR clones (clones 15, 50, 51, 61, 62 and 63) contained
blaROB genes and all shared closest homology (53% identity, 40%
query cover) with a hypothetical protein from Staphylococcus
haemolyticus. Direct PCR amplification using template metage-
nomic DNA failed to reveal any blaROB genes. Finally, blaSHV
primers did not generate amplicons from either the AmpR clones
or uncloned metagenomic DNA.
PCR and Sanger sequencing of aminoglycoside resistant
clones
Degenerate PCR primers were employed to determine whether
the fosmids conferring gentamicin resistance contained homo-
logues of known aminoglycoside resistance genes. Acetylation,
adenylation and phosphorylation genes were detected in the
Antibiotic Resistance in the Infant Gut Microbiota
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GentR clones (Table 2). With respect to aminoglycoside acetyla-
tion-associated genes, aac (3)-I, aac (3)-II, aac (3)-III and aac (3)-VI
were not detected in either the 13 GentR clones or in the uncloned
metagenomic DNA. However, all 13 GentR clones contained an
aac (6) gene that most closely resembled a Pseudomonas
fluorescens gene. Interestingly, the aac (6) primers did not generate
amplicons when used directly with metagenomic DNA (Table 3).
Aminoglycoside adenylation, ant (20)-Ia, genes were detected in 9
of the 13 GentR clones (Table 2). Eight of these 9 GentR clones
shared closest homology with aminoglycoside 29 O adenyltrans-
ferase genes found in Pasteurella multocida, while that from the
remaining clone resembled an E. coli associated gene. Similar
sources of these genes were also detected when PCR was
performed with the ant (20)-Ia primers and uncloned metagenomic
template DNA (Table 3). Following cloning and sequencing of
these amplicons, it was apparent that 4 of the 5 clones contained
ant (20)-Ia genes sharing closest homology (99% identity, 97%
query cover) with genes present in P. multocida (identical to the
source of these genes detected in the GentR clones). The fifth clone
that was sequenced contained insert DNA sharing closest
homology with a nucleotidyltransferase from A. baumannii (99%
identity, 97% query cover).
When primers were applied to investigate the presence of
aminoglycoside phosphorylation genes using aph (20)-Id primers,
10 of the 13 GentR clones contained these genes (Table 2). A
number of these GentR clones (5, 6, 8, 11, 12, 13 and 34) shared
closest homology with phosphorylation genes from Clostridium
difficile (100% identity and 94% query cover). When these aph
(20)-Id primers were used directly with metagenomic DNA, genes
sharing homology with C. difficile (identical to those detected in
the GentR clones), Enterococcus faecium and an unknown source
of aph (20)-Id genes were detected (Table 3).
Finally, using 2 different primer sets, it was found that all GentR
clones contained the bifunctional gene aac(69)-le-aph(20)-Ia. These
Table 1. Primers used in this study.
Target gene family Primer name Sequence 59-39 Annealing temperature 6C Ref.
b-lactamase genes
blaTEM RH605 TTTCGTGTCGCCCTTATTCC 60 Bailey et al. (2011)
RH606 CCGGCTCCAGATTTATCAGC
Bla_TEMF TGGGTGCACGAGTGGGTTAC 57 Tenover et al. (1994)
Bla_TEMR TTATCCGCCTCCATCCAGTC
blaROB Bla_ROBF ATCAGCCACACAAGCCACCT 62 Tenover et al. (1994)
Bla_ROBR GTTTGCGATTTGGTATGCGA
blaSHV Bla_SHVF CACTCAAGGATGTATTGTG 58 Brin˜as et al. (2002)
Bla_SHVR TTAGCGTTGCCAGTGCTCG
blaOXA Bla_OXAF TTCAAGCCAAAGGCACGATAG 64 Brin˜as et al. (2002)
Bla_OXAR TCCGAGTTGACTGCCGGGTTG
blaCTX-M Bla_CTX-MF CGTTGTAAAACGACGGCCAGTGAATGT-
GCAGYACCAGTAARGTKATGGC
55 Monstein et al. (2009)
Bla_CTX-MR TGGGTRAARTARGTSACCAGAAYCAGCGG 60
AG resistance genes
aac (3)-I Faac3-1 TTCATCGCGCTTGCTGCYTTYGA 58 Heuer et al. (2002)
Raac3-1 GCCACTGCGGGATCGTCRCCRTA
aac (3)-II/VI Faac3-2 GCGCACCCCGATGCMTCSATGG 58
Raac3-2 GGCAACGGCCTCGGCGTARTGSA
Facc3-6 GCCCATCCCGACGCATCSATGG
Raac3-6 CGCCACCGCTTCGGCATARTGSA
aac (69)-II/Ib Faac6 CACAGTCGTACGTTGCKCTBGG 58
Raac6 CCTGCCTTCTCGTAGCAKCGDAT
ant (20)-Ia Fant TGGGCGATCGATGCACGGCTRG 58
Rant AAAGCGGCACGCAAGACCTCMAC
aph(20)-I Faphc CCCAAGAGTCAACAAGGTGCAGA 55
Faphd GGCAATGACTGTATTGCATATGA 55
Raph GAATCTCCAAAATCRATWATKCC
aac(69)-Ie-aph(20)-Ia aac-aphF GAGCAATAAGGGCATACCAAAAATC 47 De Fatı´ma Silva Lopes
et al. (2003)
aac-aphR CCGTGCATTTGTCTTAAAAAACTGG
aac6-aph2F CCAAGAGCAATAAGGGCATACC 55 Schmitz et al. (1999)
aac6-aph2R CACACTATCATAACCATCACCG
AG: aminoglycoside.
doi:10.1371/journal.pone.0108016.t001
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genes shared homology with bifunctional aac(69)-le-aph(20)-Ia
genes from Enterococcus faecalis (clones 3, 4, 5, 6 and 11),
Streptococcus epidermidis (clones 4, 8 and 13), E. faecium (clone
10) and Enterococcus sp. (clone 5) (Table 2). Sequencing of the
amplicons generated with uncloned metagenomic DNA, identified
genes sharing closest homology with bifunctional genes from E.
faecalis (which were distinct from those detected in the GentR
clones) and from S. aureus (WP_001028140.1), a source which
was not detected using PCR analysis on the GentR clones
(Table 3).
MIC analysis of ampicillin and gentamicin resistant clones
To determine the level of resistance conferred by the fosmid-
cloned metagenomic DNA to ampicillin or gentamicin, MIC
assays were conducted. A representative subset of 22 of the 100
AmpR clones (including those containing genes only detected in a
limited number of clones e.g. blaOXA and clones containing
multiple b-lactam resistance genes) and all 13 of the GentR clones
were studied. MICs were compared to the host EPI 300-T1R E.
coli cells containing the empty pCC1FOS fosmid.
The AmpR clones exhibited a 2- (clone 6) to 512- (clone 2) fold
increase in resistance to ampicillin compared to the empty fosmid
control (Table 4). The large variation in MICs between the AmpR
clones highlighted the fact that different, but related, genes
conferred different levels of resistance to the host E. coli cells, most
likely due to differences in expression/translation in the surrogate
E. coli host. Clones containing multiple b-lactam resistance genes
(clones 2, 3, 4, 62, 128, 136 and 140), including blaTEM, blaCTX-M
and blaOXA genes, were found to confer the highest levels of
resistance to b-lactams. In contrast, when MICs were conducted
on the 13 GentR clones, all clones showed similar levels of
resistance to gentamicin with MICs of 4-8 fold higher than that of
the control (Table 5).
Discussion
The infant gut microbiota is in constant flux during the first two
years of life [23]. During this time there is considerable
opportunity for the infant to acquire antibiotic resistant popula-
tions. Given the opportunity, resistant populations could become
dominant in the gut following antibiotic therapy or may contribute
to antibiotic resistance gene dissemination. In this study we set out
to use a metagenomic fosmid bank to functionally screen the gut
microbiota of 22 healthy infants who had not been treated with
antibiotics, for antibiotic resistance genes. Additionally, we wanted
to perform PCR analysis directly on uncloned metagenomic DNA
to determine if additional genes would be detected, that had not
been captured in the functional bank. Using such an approach, we
Figure 1. Schematic of the approach applied in this study.
doi:10.1371/journal.pone.0108016.g001
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have demonstrated that the infant gut is a source of a variety of
genes encoding resistance to aminoglycosides and b-lactams. One
hundred AmpR clones were detected in the gut microbiota of
infants through screening of the metagenomic fosmid bank.
Applying a PCR-based approach to determine the resistance genes
present in the resistant clones, we detected blaTEM, blaOXA,
blaROB and blaCTX-M genes. Interestingly, the blaTEM genes
detected exhibited greatest homology with genes from uncultured
bacteria. Such results highlighted the ability of our strategy to
reveal genes from more cryptic sources, including b-lactam
Table 2. Identity of ampicillin and gentamicin resistant genes amplified from the infant gut metagenomic bank.
Accession number Primer name
Clones in which genes
detected Closest homologue* E value % ID
ROB Bla_ROBF
Bla_ROBR
WP_016930608.1 15,50,51,61,62,63 Hypothetical protein S. haemolyticus 1e220 53
TEM RH605
RH606
Bla_TEMF
Bla_TEMR
AGH19654.1 2, 5,6 b-lactamase partial uncultured soil bacterium 1e2134 100
AGH19657.1 3,16,17 b-lactamase partial uncultured soil bacterium 4e2139 99
AAP93842.1 17,18 b-lactamase C. freudii 5e2138 99
AEN75339.1 4 b-lactamase TEM Shigella sp. 4e2141 99
AGH19655.1 2,123 b-lactamase uncultured soil bacterium 2e297 100
AGH19650.1 3,4,10,128 b-lactamase uncultured soil bacterium 7e297 100
AAP93841.1 126 b-lactamase S. marcescens 2e297 98
CTX-M Bla_CTX-MF
Bla_CTX-MR
AEZ49563.1 2,3 b-lactamase CTX-M-1 E. coli 2e2116 99
BAD16611.1 4,136 b-lactamase CTX-M-36 E. coli 1.10e2127 99
AAB22638.1 140,145 b-lactamase penicillin amido b-lactamase
hydrolase E. coli
2e2128 100
OXA Bla_OXAF
Bla_OXAR
AGN75112.1 140 TEM-190 b-lactamase E. coli 2e204 38
ADZ11076.1 132 b-lactamase TEM E. coli 2e240 71
ant (20)-Ia Fant
Rant
YP_005176240.1 3,7,9,10,11,12,33,34,36 AG 2 O9 adenyltransferase P. multocida 1e279 96
WP_000292466.1 8 AG adenyltransferase E. coli 5e275 96
aph (20)-Id Faphd
Raph
WP_0214010241.1 5, 6, 8,11,12,13, 34, aph C. difficile 4e295 100
aac(6) Faac6
Raac6
AAA25680.1 34,36 AG 6’ N acetyltransferase P. fluorescens 5e233 97
aac (69)-Ie-aph (20)-Ia aac-aphF
aac-aphR
aac6-aph2F
aac6-aph2R
WP_010714603.1 3,4,5,6,11 bifunctional aac (69)-Ie-aph (20) E. faecalis 1e296 100
AFR11868.1 4,8,13 bifunctional 6’ AG N acetyltransferase/2’’ AG
phosphotransferase S. epidermidis
8e232 98
AFM29914.1 5 Gentamicin resistance protein Enterococcus sp. 3e230 96
WP_010782592.1 10 Bifunctional AAC/APH E. faecium 1e231 98
* Result presented is the closest homologue to our sequence (based on lowest E value).
doi:10.1371/journal.pone.0108016.t002
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resistance genes from sources not accessible through classical
culture-based approaches. It was also notable that we detected
such a prevalence of ampicillin resistance genes, and that they
appear to have originated from a diverse range of species.
Nonetheless, the majority of the b-lactam resistance genes
identified shared homology with b-lactam resistance genes present
in E. coli, Shigella and Serratia, which are common sources of
such genes [36–38]. When PCRs were performed using blaOXA
primers, just 2 of the 100 AmpR clones were found to contain such
genes. However, sequencing of these amplicons revealed that they
shared greatest homology with blaTEM genes (Table 2). Therefore,
it appears that in this instance, the infant gut microbiota did not
contain blaOXA genes and in their absence, the blaOXA primers
enabled the detection of blaTEM homologues. This is not entirely
unexpected, given previous observations of 3 sites of homology
between the amino acid sequence of the OXA 2 gene and TEM b-
lactamases [39].
This metagenomic study has successfully identified acetylation,
adenylation and phosphorylation genes conferring aminoglycoside
resistance in the infant gut microbiota. The fact that these genes
resemble genes from bacteria such as E. coli, E. faecalis, S.
epidermidis and C. difficile is not surprising given that a number of
the observed resistance genes are resident in such species
[30,40,41]. A recent study which employed a metagenomic
approach to investigate antibiotic resistance in infants, also
detected a high prevalence of aminoglycoside resistance genes
[22]. In that instance, they too identified aminoglycoside
acetylation, adenylation and phosphorylation genes in the infant
gut which shared homology with C. difficile and E. faecium. As
these bacteria may be among the first colonizers of the infant gut,
these findings support previous research which suggests antibiotic
resistance and the antibiotic resistome is established in early life,
perhaps even from birth, irrespective of antibiotic exposure, and is
closely associated with microbes from the maternal and environ-
mental sources it is exposed to during and immediately after birth
[4]. This is consistent with the apparently ubiquitous nature of
antibiotic resistance genes in the environment, with studies having
demonstrated that antibiotic resistant isolates can be detected in
individuals from remote areas of the world who lack, or who have
minimal, antibiotic exposure [42–44].
In addition to screening the fosmid metagenomic bank, a PCR-
based analysis of uncloned metagenomic DNA was also carried
out. Previous studies demonstrated the success of such an
approach with respect to detecting genes that were present at a
low level and had not been captured in the metagenomic fosmid
bank [21]. Additionally, this approach also addresses situations
whereby certain genes may not be expressed or their products may
not be functional in E. coli, e.g. as previously shown in the case of
Table 3. Sequencing results from TOPO cloning of ampicillin and gentamicin resistant genes from metagenomic DNA.
Accession # Closest homologue* E value % ID
TEM
AAL03985.1 ESBL TEM-71 K. pneumoniae 7e2154 99
WP_004207849.1 b-lactamase TEM partial K. pneumoniae 3e2153 97
WP_017431996.1 b-lactamase partial S. aureus 1e2112 84
WP_019405145.1 b-lactamase partial K. pneumoniae 6e2154 100
AEN02824.1 b-lactamase TEM-1 K. pneumoniae 4e2111 99
ADE18896.1 TEM-1 b-lactamase S. enterica 7e2112 97
ABG46354.1 ESBL E. coli 1e2139 100
AEN02826.1 b-lactamase TEM-1 K. pneumoniae 1e2108 99
CTX-M
AAB22638.1 b-lactamase penicillin amido b-lactam hydrolase E. coli 1e2139 100
AEZ49551.1 b-lactamase CTX-M-1 K. pneumoniae 5e2129 99
AEZ49563.1 b-lactamase CTX-M-1 E. coli 8e2140 97
ABG46356.1 ESBL K. pneumoniae 1e2138 99
ant (20)-Ia
YP_005176240.1 AG 2 O adenyltransferase Pasteurella multocida 1e295 99
WP_000946493.1 2 AG nucleotidyltransferase A. baumannii 3e297 99
aph (20)-Id
AAW59417.1 E. faecium aph 2 Id 5e298 90
3Sg8_9 Crystal structure of AG 2’’ phosphotransferase Tobramycin resistance gene 5e2109 100
WP_021401024.1 aph (20)-Id C. difficile 6e2108 98
aac (69)-Ie-aph (20)-Ia
WP_ 001028140.1 GNAT family acetyltransferase S. aureus 2e2109 100
AAX82584.1 Bifunctional AG modifying enzyme E. faecalis 2e2106 99
WP_002417297.1 Phosphotransferase enzyme family protein E. faecalis 4e2113 99
* Result presented is the closest homologue to our sequence based on lowest E value.
ESBL: extended spectrum b-lactamase.
AG: aminoglycoside.
doi:10.1371/journal.pone.0108016.t003
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strA and strB [45]. However, previous studies have demonstrated
that genes from at least 4 major phyla from the gut microbiome
can be functional in E. coli hosts [46]. It is also possible to create
metagenomic banks using Gram-positive hosts such as Streptomy-
ces to identify genes which may not be expressed in Gram-negative
hosts [47]. In our study, as our library was only made in a Gram-
negative host, we conducted PCR analysis directly on uncloned
metagenomic DNA, with the aim of identifying additional
resistance genes to those captured in our functional screen. Thus,
in this instance, we have demonstrated the usefulness of
supplementing functional metagenomics with a PCR-based
approach directly on metagenomic DNA to enable detection of
antibiotic resistance genes apparently originating from different
species than those that were identified during the course of the
functional screen. In the majority of cases the putative sources of
genes detected by PCR with metagenomic library isolates and with
uncloned metagenomic template DNA were similar, though in
some circumstances additional insights were provided using this
combined approach. For example, some blaTEM genes identified
from the functional screen shared closest homology with genes
from uncultured soil bacterium, whereas direct PCR-screening
highlighted homologues of genes found in K. pneumoniae, S.
aureus, S. enterica and E. coli. Furthermore, in certain instances
resistance genes were captured by the metagnomic bank (aac 6)
that were not detected when PCR analysis was completed directly
on metagnomic DNA. This demonstrates that combining different
experimental approaches allows for the most comprehensive
insight into the gut microbiota as a source of antibiotic resistance
genes. It should also be noted that, if screened for, we expect that
our metagenomic library would also uncover resistance genes for
other major families of antibiotics. Multi-drug resistant Gram-
positive bacteria represent a serious threat to human health [48].
Several recent functional metagenomic studies screened the gut
microbiota of children for resistance against antibiotics which
specifically target Gram-positive bacteria (including fosfomycin
and tigecycline) [20,22]. In the study of Moore et al., clones
resistant to antibiotics which target Gram-positive bacteria were
detected [22], demonstrating that the gut microbiota of children
and teenagers is a reservoir for resistant Gram-positive bacteria.
Thus, while our focus was resistance to aminoglycoside and b-
lactam antibiotics, future screening of this metagenomic bank for
resistance to other antibiotics would likely yield positive clones.
This study is one of a limited number that has demonstrated the
existence of antibiotic resistant genes in the healthy infant gut
microbiota using a metagenomic library approach. Although used
to investigate antibiotic resistance in environments as diverse as
gull faeces [49] or soil from apple orchards [45], to date the use of
metagenomic banks to screen the infant gut microbiota for
resistance genes has been limited [21,22]. In particular, our study
adds considerably to current data on the infant gut resistome by
supporting and supplementing existing results [22], which have
demonstrated that the infant gut is a reservoir for antibiotic
resistance. By studying 6-month-old infants with no previous
antibiotic exposure, we were able to establish a comprehensive
insight into the resistome of infants devoid of antibiotic selective
pressure. Our results supplement those of Moore et al. who
investigated antibiotic resistance in children and teenagers using
functional metagnomics [22]; however, in that instance they
examined antibiotic resistance across a wide age range (1 month to
19 years of age), while our study provides a comprehensive insight
into the infant resistome specifically at 6 months of age,
demonstrating the early development of this resistome even
without treatment with antibiotics. Additionally, we have demon-
strated the benefits of supplementing functional screening with
PCR and MIC assays, which enables the complexity of the infant
resistome to be fully appreciated.
The approach applied in our study has both strengths and
limitations. The strengths lie in the combination of approaches
employed (functional metagenomics, PCR and MICs) to provide
insights into the infant resistome. Whilst functional metagenomics
enabled the detection of genes from apparently more novel sources
Table 4. MICs of ampicillin resistant clones.
AmpR clone MIC fold difference compared to the control
2 512
3 128
4 256
5 4
6 2
10 16
15 4
16 32
17 64
18 32
50 4
51 16
61 64
62 256
63 4
123 64
126 16
128 128
132 16
136 256
140 128
145 8
doi:10.1371/journal.pone.0108016.t004
Table 5. MICs of gentamicin resistant clones.
GentR clones MIC fold difference compared to the control
3 8
4 8
5 8
6 8
7 8
8 8
9 8
10 8
11 8
12 8
13 4
33 4
34 8
doi:10.1371/journal.pone.0108016.t005
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(including uncultured soil bacteria), PCR analysis using uncloned
metagenomic DNA as a template, detected a number of gene(s)
from additional sources not captured by our functional analysis.
Moreover, MIC analysis highlighted the wide range of increased
resistance to aminoglycosides and b-lactams conferred by each of
the clone inserts. The limitations are that even using a combined
metagenomic approach, we were unable to detect novel amino-
glycoside or b-lactam resistance genes. It would be useful,
therefore, to construct an additional infant metagenomic library
using a Gram-positive host, as well as in E. coli, to investigate
whether different resistance genes could be captured and
expressed. Furthermore, it would be interesting to determine
expression levels of antibiotic resistance genes harboured by the
infant gut microbiota. We hope to apply such approaches in future
related studies.
The findings from our study are important for several reasons.
Firstly, as the infant gut is populated through complex bacterial
acquisitions from maternal, dietary and environmental sources,
there is the potential to control the populations colonizing infants,
i.e. to maximize colonization with those bacteria that may be
beneficial and pose less risk of contributing to the antibiotic
resistome. Additionally, in cases where antibiotic administration is
required, the route of antibiotic administration should be
considered carefully when different options are available. Indeed,
research using a murine model has demonstrated that antibiotic
administration through intravenous injection resulted in signifi-
cantly less, or the delayed development of, antibiotic resistant
genes in gut microbiota populations compared to oral adminis-
tration [50]. Although outside the scope of the present study, it
would also seem that further investigations with respect to links
between maternal antibiotic exposure and subsequent antibiotic
resistant populations in the infant would be beneficial. In one
previous instance, tetracycline resistance (tetR) in the gut
microbiota of one mother-infant pair was studied [21]. More
specifically, resistance genes from the gut microbiota of a vaginally
delivered, exclusively breastfed male infant, one month after birth,
were compared with those within the gut microbiota of his mother.
Among the findings was an observation of some identical
resistance genes in both populations, suggesting that the transfer
of antibiotic resistant populations from the mother to the infant
may occur, potentially through maternal microbiota transmission
during delivery, physical contact or through breastfeeding [21].
Others have also demonstrated shared antibiotic resistance gene
pools between mother and infant faecal samples [4], which may be
associated with resistance genes detected in breast milk. Thus, it is
likely that infant gut microbiota acquired during delivery and
breastfeeding can contribute to the development of the infant
resistome.
In our study, the gut microbiomes of 6 month-old infants, who
had not previously been treated with antibiotics, harbored diverse
antibiotic resistance genes. Metagenomic fosmid bank creation
allowed functional screening for resistance genes in the gut
microbiota of infants and revealed genes from diverse sources
including those previously linked with uncultured bacteria.
Combining this sophisticated approach with PCR techniques,
provided a particularly unique insight into the presence of
resistance genes in the infant gut microbiota. The results not only
act as a cautionary insight into the prevalence of antibiotic
resistance in infants, even in cases where no antibiotic selective
pressure occurred, but also demonstrate the power of combining
several metagenomic approaches to provide important insights
into the infant gut resistome.
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